PMBS.OB...Die Riesige Riesenchance !!! - 500 Beiträge pro Seite
eröffnet am 10.10.09 12:41:14 von
neuester Beitrag 06.01.10 19:29:24 von
neuester Beitrag 06.01.10 19:29:24 von
Beiträge: 51
ID: 1.153.575
ID: 1.153.575
Aufrufe heute: 0
Gesamt: 3.279
Gesamt: 3.279
Aktive User: 0
ISIN: US7460942003 · WKN: A12DA0
0,0001
USD
+9.900,00 %
+0,0001 USD
Letzter Kurs 02.04.19 Nasdaq OTC
Werte aus der Branche Dienstleistungen
Wertpapier | Kurs | Perf. % |
---|---|---|
0,5500 | +450,00 | |
0,9000 | +55,17 | |
4,9000 | +22,50 | |
30,00 | +18,81 | |
1,3500 | +17,39 |
Wertpapier | Kurs | Perf. % |
---|---|---|
39,20 | -15,15 | |
114,26 | -15,98 | |
2,0250 | -17,68 | |
31,00 | -24,39 | |
61,36 | -37,26 |
Hier nun der zweite Thread nachdem der erste wegen Grossschrift gelöscht worden ist .
Ich habe noch nie soviel geld in einem OTC-Wert gesteckt und das will was heißen .
Puramed ist erst seit 15 Monaten gelistet also am Anfang der Finanzkrise und daran denke ich liegt es das die Aktie noch unentdeckt ist .
Ich habe einige PMBS zwischen 30-40cent eingesammelt, es war nicht gerade einfach welche zu diesen Kursen zu bekommen .
Ich hoffe/glaube ich sitze hier auf eine Goldmiene !!!
Puramed (Pmbs.ob)
Marktkap: 5,7 M$
Kurs: 0,50 $
Shares Out : 11,99 Million
Float : 2,6 Million
Schaut euch die Präsentation an (LESENSWERT)
http://www.puramedbioscience.com/profile.html
When does PuraMed BioScience expect to launch its first commercial product and begin generating revenue?
PuraMed BioScience will launch its LipiGesic M migraine product via a direct-response infomercial scheduled for broadcast in October 2009.
When do you anticipate generating revenue?
PuraMed BioScience expects to generate revenue in October 2009, which corresponds to the date the direct response commercial is scheduled to be televised.
When do you expect to launch first product in retail or commercial environment?
PuraMed BioScience will approach retailers within 60-days from the initial airing of our LipiGesic M migraine product direct response television commercial.
Do PuraMed BioScience products require FDA approval?
Unlike prescription drugs or medications, non-prescription healthcare remedies such as PuraMed products do not require FDA approval prior to entering the market. PuraMed products are nonetheless subject to substantial FDA and other federal regulations governing their use, labeling, advertising, manufacturing and ingredients. PuraMed BioScience believes that its current and proposed development, formulation, marketing and other practices and procedures will comply fully with all governmental regulations applicable to PuraMed products.
How many products does PuraMed BioScience have in progress?
LipiGesic M for the relief of migraine headaches is the first PuraMed product that will be introduced to the market. Following its entrance into the market, two other products, LipiGesic PM for insomnia and LipiGesic H for tension headaches, will be developed and introduced. There are also product formulations for relief from canker sores, restless-leg syndrome, nighttime-reflux disorders, smoking cessation, and weight loss that will soon follow.
Gegen Mirgäne
Gegen Schlaflosigkeit
Gegen Kopfschmerzen
Ich habe noch nie soviel geld in einem OTC-Wert gesteckt und das will was heißen .
Puramed ist erst seit 15 Monaten gelistet also am Anfang der Finanzkrise und daran denke ich liegt es das die Aktie noch unentdeckt ist .
Ich habe einige PMBS zwischen 30-40cent eingesammelt, es war nicht gerade einfach welche zu diesen Kursen zu bekommen .
Ich hoffe/glaube ich sitze hier auf eine Goldmiene !!!
Puramed (Pmbs.ob)
Marktkap: 5,7 M$
Kurs: 0,50 $
Shares Out : 11,99 Million
Float : 2,6 Million
Schaut euch die Präsentation an (LESENSWERT)
http://www.puramedbioscience.com/profile.html
When does PuraMed BioScience expect to launch its first commercial product and begin generating revenue?
PuraMed BioScience will launch its LipiGesic M migraine product via a direct-response infomercial scheduled for broadcast in October 2009.
When do you anticipate generating revenue?
PuraMed BioScience expects to generate revenue in October 2009, which corresponds to the date the direct response commercial is scheduled to be televised.
When do you expect to launch first product in retail or commercial environment?
PuraMed BioScience will approach retailers within 60-days from the initial airing of our LipiGesic M migraine product direct response television commercial.
Do PuraMed BioScience products require FDA approval?
Unlike prescription drugs or medications, non-prescription healthcare remedies such as PuraMed products do not require FDA approval prior to entering the market. PuraMed products are nonetheless subject to substantial FDA and other federal regulations governing their use, labeling, advertising, manufacturing and ingredients. PuraMed BioScience believes that its current and proposed development, formulation, marketing and other practices and procedures will comply fully with all governmental regulations applicable to PuraMed products.
How many products does PuraMed BioScience have in progress?
LipiGesic M for the relief of migraine headaches is the first PuraMed product that will be introduced to the market. Following its entrance into the market, two other products, LipiGesic PM for insomnia and LipiGesic H for tension headaches, will be developed and introduced. There are also product formulations for relief from canker sores, restless-leg syndrome, nighttime-reflux disorders, smoking cessation, and weight loss that will soon follow.
Gegen Mirgäne
Gegen Schlaflosigkeit
Gegen Kopfschmerzen
Der wird hoffentlich für eine explosion in meinem Depot sorgen !
Homepage
http://www.puramedbioscience.com/index.html
Russ Mitchell, Chairman and CEO
Mr. Mitchell formerly served as Chairman and CEO of Dotronix, Inc., currently Wind Energy America, Inc. (OTCBB: WNEA). Prior to his role at PuraMed Bioscience, Inc. he was the founder of Mitchell Health Marketing Alliance, Inc., (formerly Mitchell Health Technologies) which he established in 1994. MHMA services over 48,000 retail locations nationwide, and specializes in the marketing and distribution of non-prescription drugs and nutritional supplements. In addition to building a national sales network covering the U.S. Food, Drug and Mass categories from the ground up, Mr. Mitchell has personally met with and negotiated with key buyers and officers of the top 100 retail chains and wholesalers on an ongoing basis for over a decade.
Mr. Mitchell has been a pioneer in establishing the marketing value of clinical trials to demonstrate the effectiveness of OTC remedies. Mr. Mitchell brings with him over 23 years of sales and marketing experience, including 14 years of national level management, sales, marketing and new product development in the drug and nutritional supplement industry. He is experienced in the formulation and manufacturing of prescription drugs, OTC drugs and nutritional supplements in tablet, capsule, powder and liquid form.
Homepage
http://www.puramedbioscience.com/index.html
Russ Mitchell, Chairman and CEO
Mr. Mitchell formerly served as Chairman and CEO of Dotronix, Inc., currently Wind Energy America, Inc. (OTCBB: WNEA). Prior to his role at PuraMed Bioscience, Inc. he was the founder of Mitchell Health Marketing Alliance, Inc., (formerly Mitchell Health Technologies) which he established in 1994. MHMA services over 48,000 retail locations nationwide, and specializes in the marketing and distribution of non-prescription drugs and nutritional supplements. In addition to building a national sales network covering the U.S. Food, Drug and Mass categories from the ground up, Mr. Mitchell has personally met with and negotiated with key buyers and officers of the top 100 retail chains and wholesalers on an ongoing basis for over a decade.
Mr. Mitchell has been a pioneer in establishing the marketing value of clinical trials to demonstrate the effectiveness of OTC remedies. Mr. Mitchell brings with him over 23 years of sales and marketing experience, including 14 years of national level management, sales, marketing and new product development in the drug and nutritional supplement industry. He is experienced in the formulation and manufacturing of prescription drugs, OTC drugs and nutritional supplements in tablet, capsule, powder and liquid form.
Antwort auf Beitrag Nr.: 38.152.646 von BrauchGeld am 10.10.09 12:41:14ich sitze hier auf eine Goldmiene !!
Alle machen mal gute Miene zu Deinem Blödsinn.........
Alle machen mal gute Miene zu Deinem Blödsinn.........
Antwort auf Beitrag Nr.: 38.152.735 von EureFrau am 10.10.09 13:03:31ich sitze hier auf eine Goldmiene !! <<< so habe ich das aber nicht geschrieben also nicht die tatsachen verdrehen sowas kann ich nicht leiden .
Bisher war es eigentlich immer ein gutes Zeichen für das Investment wenn sich ahnungslose gemeldet haben ..
Bisher war es eigentlich immer ein gutes Zeichen für das Investment wenn sich ahnungslose gemeldet haben ..
Antwort auf Beitrag Nr.: 38.152.646 von BrauchGeld am 10.10.09 12:41:14Ich habe noch nie soviel geld in einem OTC-Wert gesteckt und das will was heißen .
Ist das jetzt sowas wie ein Gütesiegel?
Ist das jetzt sowas wie ein Gütesiegel?
Antwort auf Beitrag Nr.: 38.152.762 von BrauchGeld am 10.10.09 13:12:271. heisst es mine
2. einer
soviel dazu
2. einer
soviel dazu
Antwort auf Beitrag Nr.: 38.152.646 von BrauchGeld am 10.10.09 12:41:14hoffentlich gewinnst du, dann kannst dir mal einen guten deutschkurs leisten
Antwort auf Beitrag Nr.: 38.152.974 von suuperbua am 10.10.09 14:36:36hoffentlich gewinnst du, dann kannst dir mal einen guten deutschkurs leisten
Dein Deutschkurs kannst du dir sonst wohin schieben solche Vorschläge kommen wohl von typen die Deutschland noch nie verlassen haben .
Übrigens gehts hier um Börse nicht um Deutsch ,anscheinend können manche halt nur durch dumme kommentare auffallen .
Wie gesagt sobald sich loser melden ist das ein gutes Zeichen ..
Dein Deutschkurs kannst du dir sonst wohin schieben solche Vorschläge kommen wohl von typen die Deutschland noch nie verlassen haben .
Übrigens gehts hier um Börse nicht um Deutsch ,anscheinend können manche halt nur durch dumme kommentare auffallen .
Wie gesagt sobald sich loser melden ist das ein gutes Zeichen ..
Antwort auf Beitrag Nr.: 38.153.310 von BrauchGeld am 10.10.09 16:56:48werde das mal beobachten nächste woche.
gruß ultra
gruß ultra
man sollte diesen thread wegen
schwachsinn
löschen
schwachsinn
löschen
Antwort auf Beitrag Nr.: 38.153.692 von Coxos am 10.10.09 20:30:45Ganz deiner Meinung!
Antwort auf Beitrag Nr.: 38.152.646 von BrauchGeld am 10.10.09 12:41:14Ich habe noch nie soviel geld in einem OTC-Wert gesteckt und das will was heißen .
das bedeutet lediglich, dass dreiMarkfuffzig Lemmingkohle in einer Luftnummer stecken
im übrigen : auf Volkshochschulen werden Deutschkurse angeboten, in denen ehemalige Klippschüler Defizite aufarbeiten können.
schau dir doch mal diese Angebote an - ist bestimmt von Vorteil für dich....
das bedeutet lediglich, dass dreiMarkfuffzig Lemmingkohle in einer Luftnummer stecken
im übrigen : auf Volkshochschulen werden Deutschkurse angeboten, in denen ehemalige Klippschüler Defizite aufarbeiten können.
schau dir doch mal diese Angebote an - ist bestimmt von Vorteil für dich....
Eine andere Meinung zu haben ist das Eine.
Diese aber in absolut daemlichen Kommentaren abzugeben etwas Anderes.
Nachrichten einfach mal ganz lesen!
Ich denke dass hier eine Anlage bis Jahresende nicht weniger spekulativ aussichtsreich ist, als bei einer WaMu oder Ecotality.
Diese aber in absolut daemlichen Kommentaren abzugeben etwas Anderes.
Nachrichten einfach mal ganz lesen!
Ich denke dass hier eine Anlage bis Jahresende nicht weniger spekulativ aussichtsreich ist, als bei einer WaMu oder Ecotality.
Das Geschaeftsmodell rezeptfreie Standard Medikamente neu zu verpacken und zu vermarkten mag langweilig erscheinen, ist zum Geldverdienen aber ganz sicher geeignet.
Man muss nicht immer erst ein Rad erfinden und die Entwicklung jahrelang versuchen irgendwie vor zu finanzieren bis vielleicht mal ein Absatz und Umsatz kommt.
Also ich finde eine Idee, mit einfachen Mitteln Geld zu verdienen, ganz und garnicht doof.
Man muss nicht immer erst ein Rad erfinden und die Entwicklung jahrelang versuchen irgendwie vor zu finanzieren bis vielleicht mal ein Absatz und Umsatz kommt.
Also ich finde eine Idee, mit einfachen Mitteln Geld zu verdienen, ganz und garnicht doof.
Antwort auf Beitrag Nr.: 38.153.872 von Deeskalationsstrateg am 10.10.09 21:48:56das bedeutet lediglich, dass dreiMarkfuffzig Lemmingkohle in einer Luftnummer stecken breites Grinsen
Mit "dreimarkfuffzig" kommt man bei deiner Mutti weiter aber mit sicherheit nicht an der Börse .
So sind se halt die Hartz4-Empfänger wenn man schon keine kohle hat dann wollen wir doch mal provozieren .
Das Niveau könnte automatisch steigen wenn man diesen Dreckspack den It-Anschluß verbieten würde das nenne ich reine Verschwendung der Steuergelder.
Pfui
Mit "dreimarkfuffzig" kommt man bei deiner Mutti weiter aber mit sicherheit nicht an der Börse .
So sind se halt die Hartz4-Empfänger wenn man schon keine kohle hat dann wollen wir doch mal provozieren .
Das Niveau könnte automatisch steigen wenn man diesen Dreckspack den It-Anschluß verbieten würde das nenne ich reine Verschwendung der Steuergelder.
Pfui
Euch ist hier nicht mehr zu helfen.
Meckert ihr doch weiter so dumm rum, ich schau mir das Teil mal ne Weile lang an und dann schaumamal...aber dieser Thread ist definitiv nicht mein Ding. Ceao!
Meckert ihr doch weiter so dumm rum, ich schau mir das Teil mal ne Weile lang an und dann schaumamal...aber dieser Thread ist definitiv nicht mein Ding. Ceao!
Antwort auf Beitrag Nr.: 38.155.323 von GaneshMK am 11.10.09 16:39:16@Datteljongleur
Ist das jetzt sowas wie ein Gütesiegel?
NEIN ist es nicht das beudetet nur das ich als normalerweise vorsichtiger Anleger viel geld in Puramed gesteckt habe .
------
@GaneshMK
Sorry das ist normalerweise nicht meine art aber manchmal ist es bei den geistesgestörten hier unvermeidlich ..
Das Geschaeftsmodell rezeptfreie Standard Medikamente neu zu verpacken und zu vermarkten mag langweilig erscheinen, ist zum Geldverdienen aber ganz sicher geeignet.
Es müsste heißen : rezeptfreie Standard Medikamente neu zu Formulieren und zu vermarkten .
----------------------------------------------------------------
So nun zurück zu Puramed ....
Upcoming Events
October 15, 2009 – New York Financial Road Show
mehr über die Produkte :
http://www.puramedbioscience.com/migraine.html
http://www.puramedbioscience.com/sleep.html
http://www.puramedbioscience.com/tension.html
Ist das jetzt sowas wie ein Gütesiegel?
NEIN ist es nicht das beudetet nur das ich als normalerweise vorsichtiger Anleger viel geld in Puramed gesteckt habe .
------
@GaneshMK
Sorry das ist normalerweise nicht meine art aber manchmal ist es bei den geistesgestörten hier unvermeidlich ..
Das Geschaeftsmodell rezeptfreie Standard Medikamente neu zu verpacken und zu vermarkten mag langweilig erscheinen, ist zum Geldverdienen aber ganz sicher geeignet.
Es müsste heißen : rezeptfreie Standard Medikamente neu zu Formulieren und zu vermarkten .
----------------------------------------------------------------
So nun zurück zu Puramed ....
Upcoming Events
October 15, 2009 – New York Financial Road Show
mehr über die Produkte :
http://www.puramedbioscience.com/migraine.html
http://www.puramedbioscience.com/sleep.html
http://www.puramedbioscience.com/tension.html
Wie im Titel schon erwähnt ich sehe hier riesiges Potential ...
http://blog.qualitystocks.net/?cat=688
With a management team bringing more than 80 years of combined industry experience, a product line addressing major healthcare needs with many competitive advantages, and a well thought-out business plan, this company is well on its way to success in the multi-billion dollar OTC medicine market. Continue to watch this company as it strives to dramatically improve the quality of life for millions of Americans.
http://blog.qualitystocks.net/?cat=688
With a management team bringing more than 80 years of combined industry experience, a product line addressing major healthcare needs with many competitive advantages, and a well thought-out business plan, this company is well on its way to success in the multi-billion dollar OTC medicine market. Continue to watch this company as it strives to dramatically improve the quality of life for millions of Americans.
Antwort auf Beitrag Nr.: 38.155.496 von BrauchGeld am 11.10.09 17:55:58das beudetet nur das ich als normalerweise vorsichtiger Anleger viel geld in Puramed gesteckt habe .
der geneigte Leser möge die schräds von @BrauchGeld sich zu Gemüte führen :
samt und sonders Biotech-Werte
und so jemand charakterisiert sich als vorsichtiger Anleger
selbstverständlich ist es nicht verboten, hochspekulativ an der Börse tätig zu sein.
wer sich dann aber als vorsichtig charakterisiert, sollte vielleicht dringend einen guten Arzt konsultieren....
der geneigte Leser möge die schräds von @BrauchGeld sich zu Gemüte führen :
samt und sonders Biotech-Werte
und so jemand charakterisiert sich als vorsichtiger Anleger
selbstverständlich ist es nicht verboten, hochspekulativ an der Börse tätig zu sein.
wer sich dann aber als vorsichtig charakterisiert, sollte vielleicht dringend einen guten Arzt konsultieren....
Antwort auf Beitrag Nr.: 38.155.567 von BrauchGeld am 11.10.09 18:18:17Wo holst du nur deinen grenzenlosen Optimismus her?
Machst wohl fleissig deine Übungen jeden Morgen!
Machst wohl fleissig deine Übungen jeden Morgen!
Antwort auf Beitrag Nr.: 38.155.833 von Boersen-Guru0815 am 11.10.09 19:44:23Wo holst du nur deinen grenzenlosen Optimismus her?
Du bist erst seit 11 tage hier registriert und gehst den leuten schon auf die Nerven ,wenn ich deine Postings so ansehe dann wäre es besser wenn man dich sofort wieder sperren würde ist sowieso alles nur müll was von dir kommt .
Besser du meidest in Zukunft meine Threads das gilt für alle die nichts zum Thema zusagen haben .
Es wäre super wenn der MOD alle Postings die nichts mit der Aktie zu tun haben löschen würde .Danke
Du bist erst seit 11 tage hier registriert und gehst den leuten schon auf die Nerven ,wenn ich deine Postings so ansehe dann wäre es besser wenn man dich sofort wieder sperren würde ist sowieso alles nur müll was von dir kommt .
Besser du meidest in Zukunft meine Threads das gilt für alle die nichts zum Thema zusagen haben .
Es wäre super wenn der MOD alle Postings die nichts mit der Aktie zu tun haben löschen würde .Danke
Puramed besorgt sich etwas cash ,bald verdienen die ihr eignes geld .
PuraMed BioScience Secures Funding to Further Efforts to Reach its Goals and Objectives
SCHOFIELD, Wis., Oct. 13, 2009 (GLOBE NEWSWIRE) -- PuraMed BioScience (OTCBB:PMBS - News), a pharmaceutical company engaged in the development and marketing of a line of revolutionary, new, non-prescription medicines that treat migraine headaches, insomnia and tension-type headaches under the brand name LipiGesic(TM), announced today that it has recently secured funding in excess of $325,000 which has allowed the Company to further efforts to reach its goals and objectives.
PuraMed's funding was provided by a number of investors during the past several months, many who invested as a direct result of sampling the LipiGesic(TM) M product and discovering its high level of efficacy in treating migraine headaches.
This funding has allowed the Company to build the initial retail inventory of LipiGesic(TM) M, and to further the patent application and approval process.
In addition, funding has enabled PuraMed BioScience to complete the production of the Company's first direct response television commercial, expected to begin airing in the fourth quarter of 2009. PuraMed is also updating its web capabilities to now include a comprehensive investor section, as well as building an e-commerce component which will allow for convenient purchase and free trials of the LipiGesic(TM) M product and all future products under the LipiGesic(TM) brand name.
Due to this recent investment, PuraMed has hired an investor relations firm, Investor Awareness, Inc. (www.investorawareness.com) and a public relations firm, North Shore Public Relations, Inc. (www.northshorepr.com) which are introducing the Company to key financial and business contacts, taking the Company's management on a national financial road show to present the Company's story for investment consideration, managing corporate communications, conducting media relations and launching a social media campaign to further raise awareness of the LipiGesic(TM) brand name.
"Our successful fundraising efforts continue to allow us to pursue many initiatives that have furthered our work in launching our first product, LipiGesic(TM) M, on a national level," said PuraMed BioScience CEO Russell Mitchell. "We are now in a position to solidify our relationships with key organizations within the medical community and to move forward with our business plan to bring to market effective, affordable, non-prescription solutions for migraine headaches and other ailments."
PuraMed BioScience Secures Funding to Further Efforts to Reach its Goals and Objectives
SCHOFIELD, Wis., Oct. 13, 2009 (GLOBE NEWSWIRE) -- PuraMed BioScience (OTCBB:PMBS - News), a pharmaceutical company engaged in the development and marketing of a line of revolutionary, new, non-prescription medicines that treat migraine headaches, insomnia and tension-type headaches under the brand name LipiGesic(TM), announced today that it has recently secured funding in excess of $325,000 which has allowed the Company to further efforts to reach its goals and objectives.
PuraMed's funding was provided by a number of investors during the past several months, many who invested as a direct result of sampling the LipiGesic(TM) M product and discovering its high level of efficacy in treating migraine headaches.
This funding has allowed the Company to build the initial retail inventory of LipiGesic(TM) M, and to further the patent application and approval process.
In addition, funding has enabled PuraMed BioScience to complete the production of the Company's first direct response television commercial, expected to begin airing in the fourth quarter of 2009. PuraMed is also updating its web capabilities to now include a comprehensive investor section, as well as building an e-commerce component which will allow for convenient purchase and free trials of the LipiGesic(TM) M product and all future products under the LipiGesic(TM) brand name.
Due to this recent investment, PuraMed has hired an investor relations firm, Investor Awareness, Inc. (www.investorawareness.com) and a public relations firm, North Shore Public Relations, Inc. (www.northshorepr.com) which are introducing the Company to key financial and business contacts, taking the Company's management on a national financial road show to present the Company's story for investment consideration, managing corporate communications, conducting media relations and launching a social media campaign to further raise awareness of the LipiGesic(TM) brand name.
"Our successful fundraising efforts continue to allow us to pursue many initiatives that have furthered our work in launching our first product, LipiGesic(TM) M, on a national level," said PuraMed BioScience CEO Russell Mitchell. "We are now in a position to solidify our relationships with key organizations within the medical community and to move forward with our business plan to bring to market effective, affordable, non-prescription solutions for migraine headaches and other ailments."
Jetzt wird es auch schwierig sein welche für 50 cent zu bekommen .
Wo sind die jetzt die sich über mich lustig gemacht haben
Die Aktie kann kurzfristig locker über 5$ gehen ..
Die Aktie kann kurzfristig locker über 5$ gehen ..
Warte erstmal ab, was der SK ist. Wenn es so bleibt, dann: Herzlichen Glückwunsch
Antwort auf Beitrag Nr.: 38.215.875 von Eclipse_71 am 20.10.09 18:28:36Danke aber ich hab sowieso nicht vor zu verkaufen die bleibt schön im Depot..Ich sehe hier jede menge upside Potential
Noch kann man günstig einsteigen ....
Tja was soll ich sagen ich bin eben der beste
So leicht kann man geld verdienen wenn man es will
Eingfach nur geil
5$ ich komme
5$ ich komme
Nach Gewinnmitnahmen wieder eine gute Chance einzusteigen ..Lipigesic(Migräne) soll innerhalb 2 monaten in den Verkaufsregalen stehen .
Verkauf über Internet soll auch bald beginnen ...
www.lipigesic.com
Verkauf über Internet soll auch bald beginnen ...
www.lipigesic.com
Good news ..Lipigesic soll ab mitte November erhältlich sein ..
Marktkap aktuell gerade mal 12 Million $ !
PuraMed BioScience, Inc. to Launch E-Commerce Website for Online Purchases of Its Non-Prescription Migraine Treatment LipiGesic(TM) M
* Press Release
* Source: PuraMed BioScience
* On 9:00 am EST, Wednesday November 4, 2009
http://finance.yahoo.com/news/PuraMed-BioScience-Inc-to-pz-7…
Marktkap aktuell gerade mal 12 Million $ !
PuraMed BioScience, Inc. to Launch E-Commerce Website for Online Purchases of Its Non-Prescription Migraine Treatment LipiGesic(TM) M
* Press Release
* Source: PuraMed BioScience
* On 9:00 am EST, Wednesday November 4, 2009
http://finance.yahoo.com/news/PuraMed-BioScience-Inc-to-pz-7…
Ich werde noch sehr viel freude mit der Aktie haben ....
Antwort auf Beitrag Nr.: 38.322.617 von BrauchGeld am 04.11.09 21:54:03Ich werde noch sehr viel freude mit der Aktie haben ..
Das wünsche ich dir auch! Danke nochmals für den Tip, leider wollte (konnte) ich nicht so recht an die Sache rangehen.
Wenigstens bist du jetzt die ganzen "Oberlehrer" los, die Börsencommunity nicht so richtig von Rechtschreibkurs unterscheiden können.
War ja wirklich nervend, wie sie sich an diesem Thema festgebissen hatten.
Tja, beim Krümel kacken verpasst man oft die besten Gelegenheiten!
Viel Glück weiterhin, du "alter Goldgräber"!!!
Das wünsche ich dir auch! Danke nochmals für den Tip, leider wollte (konnte) ich nicht so recht an die Sache rangehen.
Wenigstens bist du jetzt die ganzen "Oberlehrer" los, die Börsencommunity nicht so richtig von Rechtschreibkurs unterscheiden können.
War ja wirklich nervend, wie sie sich an diesem Thema festgebissen hatten.
Tja, beim Krümel kacken verpasst man oft die besten Gelegenheiten!
Viel Glück weiterhin, du "alter Goldgräber"!!!
Antwort auf Beitrag Nr.: 38.322.999 von orfmen am 04.11.09 22:42:05Danke Orfi das wünsche ich dir auch ....
Letzte gelegenheit noch billig einzusteigen bevor die News in den nächsten 2-3 Wochen kommt ....
Bid/Ask steht bei 1,40 zu 1,70 $
Diese PR-Firma sorgt dafür das mehr Investoren auf Puramed aufmerksam werden und das bringt den Kurs in andere Dimensionen und das sorgt wiederum für ein breits Grinsen bei mir
www.investorawareness.com
How is Investor Awareness helping Puramed Bioscience and what is being done to promote the products?
Our role is to disseminate news that is already public information and bring new investors and eyes to the stock. We have already begun doing this in Chicago and New York with Atlanta planned for next week. The results so far have been great. There have been a lot of new investors and investment professionals introduced to the Company and we have seen the volume increase dramatically over the past few weeks.
What does the future hold for PMBS?
Certainly this is a great and opportunistic time to bring this story to new investors as they are soon to generate revenue.
Should anyone have any questions, they would be more than happy to answer them for you.
Diese PR-Firma sorgt dafür das mehr Investoren auf Puramed aufmerksam werden und das bringt den Kurs in andere Dimensionen und das sorgt wiederum für ein breits Grinsen bei mir
www.investorawareness.com
How is Investor Awareness helping Puramed Bioscience and what is being done to promote the products?
Our role is to disseminate news that is already public information and bring new investors and eyes to the stock. We have already begun doing this in Chicago and New York with Atlanta planned for next week. The results so far have been great. There have been a lot of new investors and investment professionals introduced to the Company and we have seen the volume increase dramatically over the past few weeks.
What does the future hold for PMBS?
Certainly this is a great and opportunistic time to bring this story to new investors as they are soon to generate revenue.
Should anyone have any questions, they would be more than happy to answer them for you.
GEEEELLLLDDDDDDDDDDDDDD
Betreff: PuraMed Launches E-Commerce Site for LipiGesic (TM) M
To PuraMed BioScience Members:
Beginning today, you can now purchase LipiGesic M, our new, safe and effective OTC migraine medication.
Visit our e-commerce site at http://www.facebook.com/l/f1584;www.mymigrainegone.com and enjoy a special offer--buy two, get one free! We're so confident you will find LipiGesic M to help relieve your migraine pain, we are offering a money-back guarantee.
Please visit our new site today and share it with your friends and family!
http://www.facebook.com/l/f1584;www.mymigrainegone.com
--------------------
To PuraMed BioScience Members:
Beginning today, you can now purchase LipiGesic M, our new, safe and effective OTC migraine medication.
Visit our e-commerce site at http://www.facebook.com/l/f1584;www.mymigrainegone.com and enjoy a special offer--buy two, get one free! We're so confident you will find LipiGesic M to help relieve your migraine pain, we are offering a money-back guarantee.
Please visit our new site today and share it with your friends and family!
http://www.facebook.com/l/f1584;www.mymigrainegone.com
--------------------
PMBS dürfte bald aus dieser Range(1,40-1,60$) nach oben ausbrechen !!!
Marktkap 18,5 Mio$
Kurs : 1,50$
Puramed wird bald noch weitere sehr interessante Produkte auf den Markt bringen ....
LipiGesic M for the relief of migraine headaches is the first PuraMed product that will be introduced to the market. Following its entrance into the market, two other products, LipiGesic PM for insomnia and LipiGesic H for tension headaches, will be developed and introduced. There are also product formulations for relief from canker sores, restless-leg syndrome, nighttime-reflux disorders, smoking cessation, and weight loss that will soon follow.
Marktkap 18,5 Mio$
Kurs : 1,50$
Puramed wird bald noch weitere sehr interessante Produkte auf den Markt bringen ....
LipiGesic M for the relief of migraine headaches is the first PuraMed product that will be introduced to the market. Following its entrance into the market, two other products, LipiGesic PM for insomnia and LipiGesic H for tension headaches, will be developed and introduced. There are also product formulations for relief from canker sores, restless-leg syndrome, nighttime-reflux disorders, smoking cessation, and weight loss that will soon follow.
Es gibt Neuigkeiten
PuraMed BioScience Secures Funding, Enables Company to Air Direct Response Commercial in Test Markets and Pursue Additional Goals and Objectives
Press Release
Source: PuraMed BioScience
On 9:00 am EST, Tuesday December 1, 2009
Buzz up! 0 Print.Companies:Puramed Bioscience Inc
SCHOFIELD, Wis., Dec. 1, 2009 (GLOBE NEWSWIRE) -- PuraMed BioScience (OTCBB:PMBS - News), a pharmaceutical company engaged in the development and marketing of a line of revolutionary, new, non-prescription medicines that treat migraine headaches, insomnia and tension-type headaches under the brand name LipiGesic(TM), announced today that it has recently secured funding through a private placement in the amount of $500,000, the largest amount to date, which will allow the Company to initiate further efforts to reach its goals and objectives as outlined in its business plan.
Related Quotes
Symbol Price Change
PMBS.OB 1.19 0.00
{"s" : "pmbs.ob","k" : "c10,l10,p20,t10","o" : "","j" : ""}
This funding has enabled PuraMed BioScience to purchase air time for the Company's first direct response television commercial, expected to begin airing within the coming weeks in select test markets. The funding will also be allocated for several business activities that will further demonstrate the effectiveness and marketability of the LipiGesic(TM) series of products.
"We are pleased to have secured the highest level of funding to date in order to continue our efforts in launching our first product, LipiGesic M, on a national level," said PuraMed BioScience CEO Russell Mitchell. "Airing our direct response commercial in test markets is the first step in introducing the LipiGesic(TM) brand to consumers. This is one component of our overall plan to make LipiGesic(TM) the most well-known and trusted brand for non-prescription medications for migraine headaches and other illnesses; we look forward to continuing our work to achieve that goal."
About the Company:
PuraMed BioScience, Inc. engages in the research, development and marketing of non-prescription medicinal and healthcare products. In addition to its leading product LipiGesic(TM) M, which provides acute relief from migraine headaches; the Company also has plans to launch LipiGesic(TM) PM that provides a remedy for insomnia and other sleep disorders as well as LipiGesic(TM) H for common tension headaches. For more information on PuraMed, visit the Company website at www.PuraMedBioScience.com, join the Company's group page on Facebook by searching "PuraMed BioScience" and follow the Company on Twitter at www.twitter.com/puramed.
Forward Looking Statements:
This news release contains forward-looking statements regarding PuraMed BioScience and its future business plans, which statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of PuraMed BioScience to be materially different than those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.
Contact:
PuraMed BioScience, Inc.Russell Mitchell, Chairman and CEO715-359-6373rmitchell@PuramedBioScience.comwww.PuramedBioScience.comInvestor Awareness, Inc.Investor Relations:Tony Schor James Foy847-945-2222www.investorawareness.comNorth Shore Public Relations, Inc.Media Contact:Renae Placinski847-945-4505Renae@northshorepr.comwww.northshorepr.com
PuraMed BioScience Secures Funding, Enables Company to Air Direct Response Commercial in Test Markets and Pursue Additional Goals and Objectives
Press Release
Source: PuraMed BioScience
On 9:00 am EST, Tuesday December 1, 2009
Buzz up! 0 Print.Companies:Puramed Bioscience Inc
SCHOFIELD, Wis., Dec. 1, 2009 (GLOBE NEWSWIRE) -- PuraMed BioScience (OTCBB:PMBS - News), a pharmaceutical company engaged in the development and marketing of a line of revolutionary, new, non-prescription medicines that treat migraine headaches, insomnia and tension-type headaches under the brand name LipiGesic(TM), announced today that it has recently secured funding through a private placement in the amount of $500,000, the largest amount to date, which will allow the Company to initiate further efforts to reach its goals and objectives as outlined in its business plan.
Related Quotes
Symbol Price Change
PMBS.OB 1.19 0.00
{"s" : "pmbs.ob","k" : "c10,l10,p20,t10","o" : "","j" : ""}
This funding has enabled PuraMed BioScience to purchase air time for the Company's first direct response television commercial, expected to begin airing within the coming weeks in select test markets. The funding will also be allocated for several business activities that will further demonstrate the effectiveness and marketability of the LipiGesic(TM) series of products.
"We are pleased to have secured the highest level of funding to date in order to continue our efforts in launching our first product, LipiGesic M, on a national level," said PuraMed BioScience CEO Russell Mitchell. "Airing our direct response commercial in test markets is the first step in introducing the LipiGesic(TM) brand to consumers. This is one component of our overall plan to make LipiGesic(TM) the most well-known and trusted brand for non-prescription medications for migraine headaches and other illnesses; we look forward to continuing our work to achieve that goal."
About the Company:
PuraMed BioScience, Inc. engages in the research, development and marketing of non-prescription medicinal and healthcare products. In addition to its leading product LipiGesic(TM) M, which provides acute relief from migraine headaches; the Company also has plans to launch LipiGesic(TM) PM that provides a remedy for insomnia and other sleep disorders as well as LipiGesic(TM) H for common tension headaches. For more information on PuraMed, visit the Company website at www.PuraMedBioScience.com, join the Company's group page on Facebook by searching "PuraMed BioScience" and follow the Company on Twitter at www.twitter.com/puramed.
Forward Looking Statements:
This news release contains forward-looking statements regarding PuraMed BioScience and its future business plans, which statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of PuraMed BioScience to be materially different than those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.
Contact:
PuraMed BioScience, Inc.Russell Mitchell, Chairman and CEO715-359-6373rmitchell@PuramedBioScience.comwww.PuramedBioScience.comInvestor Awareness, Inc.Investor Relations:Tony Schor James Foy847-945-2222www.investorawareness.comNorth Shore Public Relations, Inc.Media Contact:Renae Placinski847-945-4505Renae@northshorepr.comwww.northshorepr.com
Absolute Top Kaufkurse !!! Marktkap von 16 Mio$ ist nie und nimmer gerechtfertigt !!
2010 ist das Jahr von Puramed ...
2010 ist das Jahr von Puramed ...
PuraMed BioScience Direct Response Commercial to Launch in National Test Markets the Week of Dec. 14
Press Release
Source: PuraMed BioScience
On 9:00 am EST, Wednesday December 9, 2009
Buzz up! 0 Print.Companies:Puramed Bioscience Inc
SCHOFIELD, Wis., Dec. 9, 2009 (GLOBE NEWSWIRE) -- PuraMed BioScience (OTCBB:PMBS - News) announced today that it has recently scheduled air time for its first national direct response commercial featuring LipiGesic(TM) M, the Company's non-prescription medication for migraine headaches.
Related Quotes
Symbol Price Change
PMBS.OB 1.00 -0.02
{"s" : "pmbs.ob","k" : "c10,l10,p20,t10","o" : "","j" : ""}
The 120-second spot is scheduled to begin airing on the week of Dec. 14 in select national test markets, and will continue testing for four to six weeks. The commercial will appear on several national cable networks, such as WE tv, a network with 72 million viewers, and others that appeal to an identified target demographic for LipiGesic(TM) M.
PuraMed BioScience is a pharmaceutical company engaged in the development and marketing of a line of revolutionary, new, non-prescription medicines that treat migraine headaches, insomnia and tension-type headaches under the brand name LipiGesic(TM).
PuraMed's commercial was produced by Avalanche Creative Services, Inc. of New York City. Avalanche has successfully created and produced over 100 direct response television commercials for nutritional supplement clients in the past six years that have collectively generated over $300 million worth of revenue.
"We look forward to airing our first direct response commercial next week for LipiGesic(TM) M," said PuraMed BioScience CEO Russell Mitchell. "These national network tests will help us to best identify who is purchasing our product and analyze their experience. In addition, it will be the first time that PuraMed begins to generate revenue. After the tests, we can then go forward with a more expansive campaign utilizing the most effective direct response strategy to raise awareness and revenue."
The commercial is available for viewing on the corporate website at www.PuraMedBioScience.com. Click on the "Investor" tab, then the "Promotional Media" tab to view.
In addition to calling the toll-free number in the commercial to purchase LipiGesic(TM) M, orders can be placed through PuraMed's new e-commerce website, www.MyMigraineGone.com.
About the Company:
PuraMed BioScience, Inc. engages in the research, development and marketing of non-prescription medicinal and healthcare products. In addition to its leading product LipiGesic(TM) M, which provides acute relief from migraine headaches; the Company also has plans to launch LipiGesic(TM) PM that provides a remedy for insomnia and other sleep disorders as well as LipiGesic(TM) H for common tension headaches. For more information on PuraMed, visit the Company website at www.PuraMedBioScience.com, join the Company's group page on Facebook by searching "PuraMed BioScience" and follow the Company on Twitter at www.twitter.com/puramed.
Forward Looking Statements:
This news release contains forward-looking statements regarding PuraMed BioScience and its future business plans, which statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of PuraMed BioScience to be materially different than those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.
Contact:
PuraMed BioScience, Inc.Russell Mitchell, Chairman and CEO715-359-6373rmitchell@PuramedBioScience.com www.PuramedBioScience.comInvestor Awareness, Inc.Investor Relations:Tony Schor or James Foy847-945-2222www.investorawareness.comNorth Shore Public Relations, Inc.Media Contact:Renae Placinski847-945-4505Renae@northshorepr.com www.northshorepr.com Buzz up! 0 SendSharePrintShare this pageDeliciousTwitterMyspaceDiggStumbleUponFacebook
Press Release
Source: PuraMed BioScience
On 9:00 am EST, Wednesday December 9, 2009
Buzz up! 0 Print.Companies:Puramed Bioscience Inc
SCHOFIELD, Wis., Dec. 9, 2009 (GLOBE NEWSWIRE) -- PuraMed BioScience (OTCBB:PMBS - News) announced today that it has recently scheduled air time for its first national direct response commercial featuring LipiGesic(TM) M, the Company's non-prescription medication for migraine headaches.
Related Quotes
Symbol Price Change
PMBS.OB 1.00 -0.02
{"s" : "pmbs.ob","k" : "c10,l10,p20,t10","o" : "","j" : ""}
The 120-second spot is scheduled to begin airing on the week of Dec. 14 in select national test markets, and will continue testing for four to six weeks. The commercial will appear on several national cable networks, such as WE tv, a network with 72 million viewers, and others that appeal to an identified target demographic for LipiGesic(TM) M.
PuraMed BioScience is a pharmaceutical company engaged in the development and marketing of a line of revolutionary, new, non-prescription medicines that treat migraine headaches, insomnia and tension-type headaches under the brand name LipiGesic(TM).
PuraMed's commercial was produced by Avalanche Creative Services, Inc. of New York City. Avalanche has successfully created and produced over 100 direct response television commercials for nutritional supplement clients in the past six years that have collectively generated over $300 million worth of revenue.
"We look forward to airing our first direct response commercial next week for LipiGesic(TM) M," said PuraMed BioScience CEO Russell Mitchell. "These national network tests will help us to best identify who is purchasing our product and analyze their experience. In addition, it will be the first time that PuraMed begins to generate revenue. After the tests, we can then go forward with a more expansive campaign utilizing the most effective direct response strategy to raise awareness and revenue."
The commercial is available for viewing on the corporate website at www.PuraMedBioScience.com. Click on the "Investor" tab, then the "Promotional Media" tab to view.
In addition to calling the toll-free number in the commercial to purchase LipiGesic(TM) M, orders can be placed through PuraMed's new e-commerce website, www.MyMigraineGone.com.
About the Company:
PuraMed BioScience, Inc. engages in the research, development and marketing of non-prescription medicinal and healthcare products. In addition to its leading product LipiGesic(TM) M, which provides acute relief from migraine headaches; the Company also has plans to launch LipiGesic(TM) PM that provides a remedy for insomnia and other sleep disorders as well as LipiGesic(TM) H for common tension headaches. For more information on PuraMed, visit the Company website at www.PuraMedBioScience.com, join the Company's group page on Facebook by searching "PuraMed BioScience" and follow the Company on Twitter at www.twitter.com/puramed.
Forward Looking Statements:
This news release contains forward-looking statements regarding PuraMed BioScience and its future business plans, which statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of PuraMed BioScience to be materially different than those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.
Contact:
PuraMed BioScience, Inc.Russell Mitchell, Chairman and CEO715-359-6373rmitchell@PuramedBioScience.com www.PuramedBioScience.comInvestor Awareness, Inc.Investor Relations:Tony Schor or James Foy847-945-2222www.investorawareness.comNorth Shore Public Relations, Inc.Media Contact:Renae Placinski847-945-4505Renae@northshorepr.com www.northshorepr.com Buzz up! 0 SendSharePrintShare this pageDeliciousTwitterMyspaceDiggStumbleUponFacebook
Es ist schon immer ziemlich eigenartig. Da hat eine Firma jetzt Ihre Produkte im Verkauf und der Kurs fällt bei mickrigen Umsätzen.
Verkaufsdruck entstand durch die kürzlich abgeschlossene kapitalerhöhung was aktuell eine Riesenchance bietet .
Zwei Präsentation finden in Januar statt das könnte einen weiteren Schub geben .
Vermarktung für das erste Produkt (Migräne) hat begonnen ..
Marktkap : 8,8 Mio$
Kurs :0,70 $
Upcoming Events
PuraMed BioScience Financial Luncheon Presentation
- Tuesday, January 19, 2010
- 12:00 pm (event details)
PuraMed BioScience Financial Luncheon Presentation
- Wednesday, January 20, 2010
- 12:00 pm (event details)
LipiGesic™ M
LipiGesic™ M provides acute relief from migraine headaches, and contains the herbs feverfew and ginger as principal ingredients. PuraMed believes that its specific formulation of these herbs for its migraine remedy is unique and proprietary, providing relief from these severe headaches in minutes. The Company believes it will capture a material segment of the huge migraine headache remedy market. We believe that Americans spend in excess of $6 billion annually on headache pain relievers, and that over half of sufferers of migraine headaches rely exclusively on non-prescription medications.
We believe that at least 30 million Americans suffer from chronic migraine headaches with over 20 million of them having “severe” migraine conditions. Thus migraine headaches constitute a severe and disabling condition for millions of people. We further believe that the economic burden alone to the U.S. economy is in excess of $20 billion annually.
LipiGesic™ M is effective, available as a non-prescription remedy, without any known side effects, and affordable compared to more expensive migraine drugs based on prescription chemical formulations.
LipiGesic™ PM
LipiGesic™ PM is a new class of non-prescription sleep aid without any known side effects, and contains a proprietary blend of natural ingredients including Valerian, St. John’s Wort, and Chamomile. We believe that the proprietary blend of these ingredients provides an effective remedy for insomnia and other sleep disorders. The sleep aid market features products based primarily on chemical antihistamines.
Accordingly, the LipiGesic™ PM product provides a wide open market opportunity for an effective, natural alternative to prescription medications, which are somewhat addictive and often cause withdrawal symptoms and other side effects. We have priced LipiGesic™ PM as a premium sleep aid product, which provides us with a projected gross margin of approximately 80%. This large margin should leave us substantial room for ample introductory promotion, product allowances and other incentives conducive to achieving rapid market penetration.
Similar to the migraine remedy market, the market for sleep aid products represents a very large segment of the overall healthcare products marketplace. We believe that over half of all adults in the U.S. suffer from sleep disorders, and that many of them experience persistent insomnia. The National Center on Sleep Disorders has reported that there are as many as 70 million problem sleepers in the U.S. with many of them suffering from chronic sleep disorders. We believe that insomnia is second only to pain as a healthcare complaint.
Future LipiGesic™ Products
We have completed development of additional non-prescription products, which we intend to launch commercially over the next couple years after establishing a solid market for our initial two products. These other PuraMed products include:
LipiGesic™ H – provides relief for common tension headaches which afflict a majority of American adults from time to time. This remedy provides headache relief features a unique proprietary formulation of St. John’s Wort and common aspirin.
LipiGesic™ Smoker’s Pal – provides relief from the symptoms associated with nicotine withdrawal with the added benefit of an appetite suppressant.
LipiGesic™ RLS – provides relief of problematic leg cramps associated with Restless Leg Syndrome affecting a large segment of the population in the U.S.
LipiGesic™ GI – provides relief of symptoms associated with nighttime reflux disorders.
LipiGesic™ CS – provides fast relief for canker sore outbreaks.
When introduced commercially, these other products will be packaged and branded much like the initial LipiGesic™ products, since we intend to devote substantial efforts and resources toward gaining a favorable and consistent brand and packaging for all PuraMed products to attempt to make them instantly recognizable on retail store shelves.
Zwei Präsentation finden in Januar statt das könnte einen weiteren Schub geben .
Vermarktung für das erste Produkt (Migräne) hat begonnen ..
Marktkap : 8,8 Mio$
Kurs :0,70 $
Upcoming Events
PuraMed BioScience Financial Luncheon Presentation
- Tuesday, January 19, 2010
- 12:00 pm (event details)
PuraMed BioScience Financial Luncheon Presentation
- Wednesday, January 20, 2010
- 12:00 pm (event details)
LipiGesic™ M
LipiGesic™ M provides acute relief from migraine headaches, and contains the herbs feverfew and ginger as principal ingredients. PuraMed believes that its specific formulation of these herbs for its migraine remedy is unique and proprietary, providing relief from these severe headaches in minutes. The Company believes it will capture a material segment of the huge migraine headache remedy market. We believe that Americans spend in excess of $6 billion annually on headache pain relievers, and that over half of sufferers of migraine headaches rely exclusively on non-prescription medications.
We believe that at least 30 million Americans suffer from chronic migraine headaches with over 20 million of them having “severe” migraine conditions. Thus migraine headaches constitute a severe and disabling condition for millions of people. We further believe that the economic burden alone to the U.S. economy is in excess of $20 billion annually.
LipiGesic™ M is effective, available as a non-prescription remedy, without any known side effects, and affordable compared to more expensive migraine drugs based on prescription chemical formulations.
LipiGesic™ PM
LipiGesic™ PM is a new class of non-prescription sleep aid without any known side effects, and contains a proprietary blend of natural ingredients including Valerian, St. John’s Wort, and Chamomile. We believe that the proprietary blend of these ingredients provides an effective remedy for insomnia and other sleep disorders. The sleep aid market features products based primarily on chemical antihistamines.
Accordingly, the LipiGesic™ PM product provides a wide open market opportunity for an effective, natural alternative to prescription medications, which are somewhat addictive and often cause withdrawal symptoms and other side effects. We have priced LipiGesic™ PM as a premium sleep aid product, which provides us with a projected gross margin of approximately 80%. This large margin should leave us substantial room for ample introductory promotion, product allowances and other incentives conducive to achieving rapid market penetration.
Similar to the migraine remedy market, the market for sleep aid products represents a very large segment of the overall healthcare products marketplace. We believe that over half of all adults in the U.S. suffer from sleep disorders, and that many of them experience persistent insomnia. The National Center on Sleep Disorders has reported that there are as many as 70 million problem sleepers in the U.S. with many of them suffering from chronic sleep disorders. We believe that insomnia is second only to pain as a healthcare complaint.
Future LipiGesic™ Products
We have completed development of additional non-prescription products, which we intend to launch commercially over the next couple years after establishing a solid market for our initial two products. These other PuraMed products include:
LipiGesic™ H – provides relief for common tension headaches which afflict a majority of American adults from time to time. This remedy provides headache relief features a unique proprietary formulation of St. John’s Wort and common aspirin.
LipiGesic™ Smoker’s Pal – provides relief from the symptoms associated with nicotine withdrawal with the added benefit of an appetite suppressant.
LipiGesic™ RLS – provides relief of problematic leg cramps associated with Restless Leg Syndrome affecting a large segment of the population in the U.S.
LipiGesic™ GI – provides relief of symptoms associated with nighttime reflux disorders.
LipiGesic™ CS – provides fast relief for canker sore outbreaks.
When introduced commercially, these other products will be packaged and branded much like the initial LipiGesic™ products, since we intend to devote substantial efforts and resources toward gaining a favorable and consistent brand and packaging for all PuraMed products to attempt to make them instantly recognizable on retail store shelves.
Ich denke es ist die letzte Chance nochmal welche unter 1$ zu bekommen !!!
Bid 75c
Ask 97c
Bid 75c
Ask 97c
Gute Nachrichten ...Puramed verdient jetzt offiziell geld
Launch of Direct Response Commercial Featuring LipiGesic(TM) M
SCHOFIELD, Wis., Jan. 4, 2010 (GLOBE NEWSWIRE) -- PuraMed BioScience (OTCBB:PMBS - News) announced today that it has begun to generate revenue for the first time as a result of its e-commerce website, www.MyMigraineGone.com, and direct response commercial featuring LipiGesic(TM) M, a non-prescription medication for migraine headaches.
"We are very pleased with how strong the initial results have been from our test launch of the direct response commercial," said PuraMed BioScience CEO Russell Mitchell. "We are now for the first time generating revenue and have truly begun to create awareness for our product and Company. We continue to accelerate our testing by identifying additional key markets and stations to further test our commercial," added Mitchell.
The commercial was first launched the week of Dec. 14 and will continue to air in select test markets before launching a major national direct response campaign.
The commercial is available for viewing on the corporate website at www.PuraMedBioScience.com. Click on the "Investor" tab, then the "Promotional Media" tab to view.
Launch of Direct Response Commercial Featuring LipiGesic(TM) M
SCHOFIELD, Wis., Jan. 4, 2010 (GLOBE NEWSWIRE) -- PuraMed BioScience (OTCBB:PMBS - News) announced today that it has begun to generate revenue for the first time as a result of its e-commerce website, www.MyMigraineGone.com, and direct response commercial featuring LipiGesic(TM) M, a non-prescription medication for migraine headaches.
"We are very pleased with how strong the initial results have been from our test launch of the direct response commercial," said PuraMed BioScience CEO Russell Mitchell. "We are now for the first time generating revenue and have truly begun to create awareness for our product and Company. We continue to accelerate our testing by identifying additional key markets and stations to further test our commercial," added Mitchell.
The commercial was first launched the week of Dec. 14 and will continue to air in select test markets before launching a major national direct response campaign.
The commercial is available for viewing on the corporate website at www.PuraMedBioScience.com. Click on the "Investor" tab, then the "Promotional Media" tab to view.
Bis zum Jahresende sollen alle drei Produkte (gegen Migräne ,Schlaflosigkeit und Kopfschmerzen)auf den Markt erhältlich sein !
Puramed hat beste Chancen der Highflyer 2010 zu werden !
Beitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Investoren beobachten auch:
Wertpapier | Perf. % |
---|---|
-0,53 | |
+900,00 | |
+0,80 | |
-0,35 |
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
218 | ||
107 | ||
81 | ||
75 | ||
46 | ||
39 | ||
39 | ||
33 | ||
32 | ||
32 |